lion in a Round E from Total Energy Ventures, the VC arm of French oil giant Total and Lacustrine Limited on behalf of Genting Genomics Limited. The Woodridge, III.-based firm had to back off its original plan to raise up to $100 million in an initial public offering, according to a September 2011 S-I fil